Genetic epidemiology of coronary artery disease

Epidemiologic Reviews

Volumn 19, Issue 1, 1997, Pages 80-90

  Peyser, Patricia A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY CALCIFICATION; ARTERY WALL; B SCAN; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENOTYPE; HUMAN; METHODOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0030694149     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017949     Document Type: Review

References (120)

1. 1997 Heart and stroke: statistical supplement. Dallas, TX: American Heart Association, 1996.
2. Fuster V, Ross R, Topol EJ. Atherosclerosis and coronary artery disease. Philadelphia, PA: Lippincott-Raven, 1996.
3. Ross R, Fuster V. The pathogenesis of atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia, PA: Lippincott-Raven, 1996:441-60.
4. McGill HC, Geer JC, Strong JP. Natural history of human atherosclerotic lesions. In: Sandler M, Bourne GH, eds. Atherosclerosis and its origin. New York, NY: Academic Press, 1963:43-52.
5. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 1993. (NIH publication no. 93-3095).
6. Hoeg JM. Grand rounds at the clinical center of the National Institutes of Health. Evaluating coronary heart disease risk: tiles in the mosaic. JAMA 1997;277:1387-90.
7. Pearson TA, Heiss GM. Atherosclerosis: quantitative imaging, risk factors, prevalence, and change. Circulation 1993; 87(3 suppl):II-2.
8. Grover SA, Coupal L, Hu XP. Identifying adults at increased risk of coronary disease: how well do the current cholesterol guidelines work? JAMA 1995;274:801-6.
9. Motulsky AG, Brunzell JD. The genetics of coronary atherosclerosis. In: King RA, Rotter JI, Motulsky AG, eds. The genetic basis of common diseases. New York, NY: Oxford University Press, 1992:150-69.
10. Colditz GA, Stampfer MJ, Willett WC, et al. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986;123: 48-58.
11. Colditz GA, Rimm EB, Giovannucci E, et al. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991;67:933-8.
12. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-6.
13. Bock G, Collins GM, eds. Molecular approaches to human polygenic disease. Ciba Foundation Symposium no. 130, Chichester, UK: Wiley, 1987.
14. Sing CF, Boerwinkle E, Moll PP, et al. Characterization of genes affecting quantitative traits in humans. In: Weir BS, Eisen EJ, Goodman MM, et al., eds. Proceedings of the second international conference on quantitative genetics. Sunderland, MA: Sinauer Associates, 1988:250-69.
15. Hunt SC, Hasstedt SJ, Kuida H, et al. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 1989;129:625-38.
16. Carmelli D, Swan GE, Robinette D, et al. Genetic influence on smoking - a study of male twins. N Engl J Med 1992; 327:829-33.
17. Williams RR, Hunt SC, Hopkins PN, et al. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 1993;6:319S-27S.
18. Brenn T. Genetic and environmental effects on coronary heart disease risk factors in northern Norway. The Cardiovascular Disease Study in Finnmark. Ann Hum Genet 1994; 58:369-79.
19. Mitchell BD, Kammerer CM, Blangero J, et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 1996;94:2159-70.
20. Sing CF, Moll PP. Strategies for unraveling the genetic basis of coronary artery disease. In: Berg K, Retterstol N, Refsum S, eds. From phenotype to gene in common disorders. Copenhagen, Denmark: Munksgaard, 1990:17-34.
21. Sing CF, Skolnick M, eds. Genetic analysis of common diseases: workshop on genetic analysis of common diseases: applications to predictive factors in coronary disease. New York, NY: Alan R Liss, 1979.
22. Berg K. Genetics of coronary heart disease. In: Steinberg AG, Bearn AG, Motulsky AG, et al., eds. Progress in medical genetics. Vol 5. Philadelphia, PA: WB Saunders, 1983: 35-90.
23. Rao DC, Elston RC, Kuller LH, et al., eds. Genetic epidemiology of coronary heart disease: past, present, and future. New York, NY: Alan R Liss, 1984.
24. Hopkins PN, Williams RR. Human genetics and coronary heart disease: a public health perspective. Annu Rev Nutr 1989;9:303-45.
25. Sing CF, Moll PP. Genetics of variability of CHD risk. Int J Epidemiol 1989;18(Suppl 1):S183-95.
26. Sing CF, Moll PP. Genetics of atherosclerosis. Annu Rev Genet 1990;24:171-87.
27. Nora JJ, Berg K, Nora AH. Cardiovascular diseases: genetics, epidemiology, and prevention. New York, NY: Oxford University Press, 1991:3-40.
28. Beam AG, ed. Genetics of coronary heart disease. Oslo, Norway: Institute of Medical Genetics, University of Oslo, 1992.
29. Weiss KM. Genetic variation and human disease: principles and evolutionary approaches. Cambridge, UK: Cambridge University Press, 1993.
30. Golden U, de Faire U, Berg K, eds. Genetic factors in coronary heart disease. Lancaster, UK: Kluwer Academic, 1994.
31. Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis X: proceedings of the 10th international symposium on atherosclerosis, Montreal, Quebec, Canada, October 9-14, 1994. Amsterdam, The Netherlands: Elsevier, 1995.
32. Sing CF, Boerwinkle EA. Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. In: Bock G, Collins GM, eds. Molecular approaches to human polygenic disease. Ciba Foundation Symposium no. 130. Chichester, UK: Wiley, 1987:99-127.
33. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
34. Schull WJ, Weiss KM. Genetic epidemiology: four strategies. Epidemiol Rev 1980;2:1-18.
35. Morton NE. Outline of genetic epidemiology. Basel, Switzerland: Karger, 1982.
36. Thompson EA. Pedigree analysis in human genetics. Baltimore, MD: Johns Hopkins University Press, 1986.
37. Elston RC. Modern methods of segregation analysis. In: Moolgavkar SH, Prentice RL, eds. Modern statistical methods in chronic disease epidemiology. New York, NY: Wiley, 1986:213-24.
38. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York, NY: Oxford University Press, 1993.
39. Nora JJ, Lortscher RH, Spangler RD, et al. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980;61:503-8.
40. Newman B, Selby JV, King MC, et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987;30:763-8.
41. Carmelli D, Robinette D, Fabsitz R. Concordance, discordance, and prevalence of hypertension in World War II male veteran twins. J Hypertens 1994; 12:323-8.
42. MacCluer JW. Biometrical studies to detect new genes with major effects on quantitative risk factors for atherosclerosis. Curr Opin Lipidol 1992;3:114-21.
43. Morton NE, Gulbrandsen CL, Rhoads GG, et al. Major loci for lipoprotein concentrations. Am J Hum Genet 1978;30: 583-9.
44. Moll PP, Berry TD, Weidman WH, et al. Detection of genetic heterogeneity among pedigrees through complex segregation analysis: an application to hypercholesterolemia. Am J Hum Genet 1984;36:197-211.
45. Hasstedt SJ, Ash KO, Williams RR. A re-examination of major locus hypotheses for high density lipoprotein cholesterol level using 2,170 persons screened in 55 Utah pedigrees. Am J Med Genet 1986;24:57-67.
46. Mahaney MC, Blangero J, Rainwater DL, et al. A major locus influencing plasma high-density lipoprotein cholesterol in the San Antonio Family Heart Study: segregation and linkage analyses. Arterioscler Thromb Vase Biol 1995;15: 1730-9.
47. Moll PP, Michels VV, Weidman WH, et al. Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet 1989;44:124-39.
48. Prenger VL, Beaty TH, Kwiterovich PO. Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catherization patients. Am J Hum Genet 1992;51:1047-57.
49. Hasstedt SJ, Wu L, Williams RR. Major locus inheritance of apolipoprotein B in Utah pedigrees. Genet Epidemiol 1987; 4:67-76.
50. Pairitz G, Davignon J, Mailloux H, et al. Sources of inter-individual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am J Hum Genet 1988;43:311-21.
51. Hasstedt SJ, Wilson DE, Edwards CQ, et al. The genetics of quantitative plasma Lp(a): analyses of a large pedigree. Am J Med Genet 1983;16:179-88.
52. Hasstedt SJ, Williams RR. Three alleles for quantitative Lp(a). Genet Epidemiol 1986;3:53-5.
53. Schumacher MC, Hasstedt SJ, Hunt SC, et al. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992;41:416-23.
54. Hasstedt SJ, Ramirez ME, Kuida H, et al. Recessive inheritance of a relative fat pattern. Am J Hum Genet 1989;45: 917-25.
55. Moll PP, Burns TL, Lauer RM. The genetic and environmental sources of body mass index variability. The Muscatine Ponderosity Family Study. Am J Hum Genet 1991;49: 1243-55.
56. Perusse L, Moll PP, Sing CF. Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet 1991;49:94-105.
57. Morton NE. The future of genetic epidemiology. Ann Med 1992;24:557-62.
58. Khoury MJ, Beaty TH. Applications of the case-control method in genetic epidemiology. Epidemiol Rev 1994;16: 134-50.
59. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
60. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
61. Reilly SL, Ferrell RE, Kottke BA, et al. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991;49:1155-66.
62. Reilly SL, Ferrell RE, Kottke BA, et al. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet 1992;51:1311-24.
63. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994,55:1001-18.
64. Ott J. Analysis of human genetic linkage. Rev ed. Baltimore, MD: Johns Hopkins University Press, 1991.
65. Weeks DE, Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988;42:315-26.
66. Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
67. Amos CI, Elston RC, Wilson AF, et al. A more powerful robust sib-pair test of linkage for quantitative traits. Genet Epidemiol 1989;6:435-49.
68. Ghosh S, Schork NJ. Genetic analysis of NIDDM: the study of quantitative traits. Diabetes 1996:45:1-14.
69. Boerwinkle E, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and the effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein, and triglyceride levels. Ann Hum Genet 1987;51:211-26.
70. Cooper DN, Clayton JF. DNA polymorphisms and the study of disease associations. Hum Genet 1988;78:299-312.
71. Wilson PWF, Schaefer EJ, Larson MG, et al. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vase Biol 1996;16:1250-5.
72. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
73. Luc G, Bard JM, Arveiler D, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 1994;14: 1412-19.
74. Davignon J. Apolipoprotein E polymorphism and atherosclerosis. Curr Sci 1993;5:1-21.
75. Stengard JH, Zerba KE, Pekkanen J, et al. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
76. Marshall HW, Morrison LC, Wu LL, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease: results of a prospective, angiographically controlled study. Circulation 1994;89:567-77.
77. Stengard JH, Pekkanen J, Ehnholm C, et al. Genotypes with the apolipoprotein ∈4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Genet 1996;97:677-84.
78. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion? (Editorial). Circulation 1996;94:236-9.
79. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
80. Fornage M, Turner ST, Sing CF, et al. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995;96:295-300.
81. Hanis CL, Boerwinkle E, Chakraborty R, et al. A genomewide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-6.
82. Comuzzie AG, Hixon JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15: 273-6.
83. Norman RA, Thompson DB, Foroud T, et al. Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group. Am J Hum Genet 1997;60:166-73.
84. Boerwinkle E, Utermann G. Simultaneous effects of apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42:104-12.
85. Kaprio J, Ferrell RE, Kottke BA, et al. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991;11:1330-48.
86. Kessling A, Ouellette S, Bouffard O, et al. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. Am J Hum Genet 1992;50:92-106.
87. Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
88. Boerwinkle E, Hallman DM. Genotype-by-environment interaction: it's a fact of life. In: Sing CF, Hanis CL, eds. Genetics of cellular, individual, family, and population variability. New York, NY: Oxford University Press, 1993: 93-105.
89. Nestruck AC, Bouthillier D, Sing CF, et al. Apolipoprotein E polymorphism and plasma cholesterol response to probucol. Metabolism 1987;36:743-7.
90. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-17.
91. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984;311:1144-7.
92. Kuller LH. AHA symposium/epidemiology meeting: atherosclerosis. Discussion: why measure atherosclerosis? Circulation 1993;87(3 suppl):II34-7.
93. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
94. Pearson TA. Coronary arteriography in the study of the epidemiology of coronary artery disease. Epidemiol Rev 1984;6:140-66.
95. Craven TE, Ryu JE, Espeland MA. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation 1990;82: 1230-42.
96. Riley WA, Barnes RW, Applegate WB, et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis: the Asymptomatic Carotid Artery Plaque Study. Stroke 1992;23:1062-8.
97. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
98. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
99. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1: 263-76.
100. Bielak LF, Kaufmann RB, Moll PP, et al. Small lesions in the heart identified at electron beam CT: calcification or noise? Radiology 1994;192:631-6.
101. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation 1996;94:1175-92.
102. Maher JE, Raz JA, Bielak LF, et al. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol 1996;144: 943-53.
103. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
104. Heiss G, Sharrett AR, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-6.
105. Grouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987;18: 990-6.
106. Duggirala R, Gonzalez Villalpando C, O'Leary DH, et al. Genetic basis of variation in carotid artery wall thickness. Stroke 1996;27:833-7.
107. de Andrade M, Thandi I, Brown S, et al. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995;56:1379-90.
108. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-3.
109. Detrano R, Hsiai T, Wang S, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 1996; 27:285-90.
110. Wong ND, Kouwabunpat D, Vo AN, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J 1994;127:422-30.
111. Bielak L, Maher J, Raz J, et al. Predictors of coronary artery calcification in asymptomatic adults. (Abstract). Am J Epidemiol 1995;141(suppl):S55.
112. Qiao JH, Xie PZ, Fishbein MC, et al. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb 1994;14:1480-97.
113. Reilly SL, Haviland MB, Peyser P, et al. Apolipoprotein E genotype as a predictor of presence of coronary artery calcification (CAC). (Abstract). Am J Hum Genet 1995; 57(suppl):A11.
114. Moshage WEL, Achenbach S, Seese B, et al. Coronary artery stenoses: three-dimensional imaging with electrocardio-graphically triggered contrast agent-enhanced, electron-beam CT. Radiology 1995;196:707-14.
115. Li D, Kaushikkar S, Haacke EM, et al. Coronary arteries: three-dimensional MR imaging with retrospective respiratory gating. Radiology 1996;201:857-63.
116. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
117. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995;268:1584-9.
118. Amos CI, Zhu DK, Boerwinkle E. Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet 1996;60:143-60.
119. Higgins M, Province M, Heiss G, et al. NHLBI family heart study: objectives and design. Am J Epidemiol 1996;143: 1219-28.
120. Holtzman NA. Proceed with caution: predicting genetic risks in the recombinant DNA era. Baltimore, MD: Johns Hopkins University Press, 1989.